CN Patent

CN114502144A — 包含抑制癌细胞生长的酰胺衍生物的药物制剂以及包含其的药物产品

Assigned to Hanmi Pharmaceutical Co Ltd · Expires 2022-05-13 · 4y expired

What this patent protects

本发明涉及包含含有化学式1的化合物或其可药用盐的颗粒剂以及稀释剂的药物制剂。由于优异的压片特性、脆碎度和质量均匀性，该药物制剂具有高的制剂生产率。该药物制剂具有低杂质生成量和高稳定性。

USPTO Abstract

本发明涉及包含含有化学式1的化合物或其可药用盐的颗粒剂以及稀释剂的药物制剂。由于优异的压片特性、脆碎度和质量均匀性，该药物制剂具有高的制剂生产率。该药物制剂具有低杂质生成量和高稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114502144A
Jurisdiction
CN
Classification
—
Expires
2022-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Hanmi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.